Come up with a name for your new list and we'll add to it:
aTyr Pharma raised a round of funding on July 29, 2013. Investors include
Silicon Valley Bank.
aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered…